RAMM Pharma Corp. (CSE: RAMM)

RAMM Pharma Revenue

RAMM Pharma had revenue of 1.21M CAD in the quarter ending July 31, 2024, a decrease of -9.19%. This brings the company's revenue in the last twelve months to 4.47M, down -12.50% year-over-year. In the fiscal year ending October 31, 2023, RAMM Pharma had annual revenue of 5.07M with 29.96% growth.

• Revenue (ttm): 4.47M
• Revenue Growth: -12.50%
• P/S Ratio: 0.40
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.79M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Oct 31, 2023	5.07M	1.17M	29.96%
Oct 31, 2022	3.90M	-218.63K	-5.31%
Oct 31, 2021	4.12M	-1.33M	-24.40%
Oct 31, 2020	5.44M	-165.89K	-2.96%
Oct 31, 2019	5.61M	-2.74M	-32.77%